The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the most aggressive and frequently diagnosed malignancy of the liver. Despite aggressive therapy, life expectancy of many patients in these cases is extended by only a few months. Hepatocellular carcinoma (HCC) has a particularly poor prognosis and would...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Xiao, Yi, Gong, Qiang, Wang, Wenhong, Liu, Fang, Kong, Qinghong, Pan, Feng, Zhang, Xiaoke, Yu, Changyan, Hu, Shanshan, Fan, Fang, Li, Sanhua, Liu, Yun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7405455/
https://ncbi.nlm.nih.gov/pubmed/32774165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01463-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados